Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Apollo Endosurgery Inc (APEN)

Apollo Endosurgery Inc (APEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 171,868
  • Shares Outstanding, K 40,250
  • Annual Sales, $ 62,990 K
  • Annual Income, $ -24,680 K
  • 60-Month Beta 2.26
  • Price/Sales 2.66
  • Price/Cash Flow N/A
  • Price/Book 3.04
Trade APEN with:

Options Overview Details

View History
  • Implied Volatility 75.22% ( -23.18%)
  • Historical Volatility 67.34%
  • IV Percentile 4%
  • IV Rank 34.85%
  • IV High 184.61% on 01/25/22
  • IV Low 16.69% on 04/20/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 1,859
  • Open Int (30-Day) 1,510

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.21
  • Number of Estimates 3
  • High Estimate -0.17
  • Low Estimate -0.24
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -90.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.79 +12.66%
on 05/11/22
6.33 -32.56%
on 04/21/22
-1.57 (-26.88%)
since 04/13/22
3-Month
3.79 +12.66%
on 05/11/22
7.30 -41.51%
on 03/03/22
-1.19 (-21.79%)
since 02/11/22
52-Week
3.79 +12.66%
on 05/11/22
10.39 -58.90%
on 11/16/21
-2.23 (-34.31%)
since 05/13/21

Most Recent Stories

More News
Apollo Endosurgery, Inc. (APEN) Reports Q1 Loss, Tops Revenue Estimates

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 0% and 6.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

APEN : 4.27 (+2.64%)
STIM : 2.57 (+13.72%)
Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

APEN : 4.27 (+2.64%)
Relative Strength Alert For Apollo Endosurgery

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

APEN : 4.27 (+2.64%)
Strength Seen in Inari Medical, Inc. (NARI): Can Its 6.2% Jump Turn into More Strength?

Inari Medical, Inc. (NARI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down...

NARI : 57.68 (+9.43%)
APEN : 4.27 (+2.64%)
Apollo Endosurgery to Report First Quarter Results on May 3, 2022

AUSTIN, TX / ACCESSWIRE / April 13, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (Nasdaq:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and...

APEN : 4.27 (+2.64%)
Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors

Veteran Brings 30 Years of Multinational Healthcare Leadership Experience AUSTIN, TX / ACCESSWIRE / April 4, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive...

APEN : 4.27 (+2.64%)
Apollo Endosurgery to Participate in the Cowen Healthcare Conference

AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced...

APEN : 4.27 (+2.64%)
Apollo Endosurgery, Inc. (APEN) Reports Q4 Loss, Tops Revenue Estimates

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -35% and 0.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?...

APEN : 4.27 (+2.64%)
LNSR : 7.04 (+2.92%)
Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021

- Increased adoption across all product lines in both U.S. and international - Grew fourth quarter 2021 revenue 26% AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN),...

APEN : 4.27 (+2.64%)
SARTORIUS (SARTF) Q4 Earnings and Revenues Surpass Estimates

SARTORIUS (SARTF) delivered earnings and revenue surprises of 1.24% and 1.82%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

SARTF : 292.0000 (-4.42%)
APEN : 4.27 (+2.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for...

See More

Key Turning Points

3rd Resistance Point 4.85
2nd Resistance Point 4.70
1st Resistance Point 4.49
Last Price 4.27
1st Support Level 4.13
2nd Support Level 3.98
3rd Support Level 3.77

See More

52-Week High 10.39
Fibonacci 61.8% 7.87
Fibonacci 50% 7.09
Fibonacci 38.2% 6.31
Last Price 4.27
52-Week Low 3.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar